Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OTC | P00480 | 1/20 | 0.41 |
| ▸ | DDAH1 | O94760 | 2/20 | 0.38 |
| ▸ | DPP7 | Q9UHL4 | 2/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | NOS2 | P35228 | 3/20 | 0.36 |
| ▸ | NOS3 | P29474 | 2/20 | 0.36 |
| ▸ | NOS1 | P29475 | 2/20 | 0.36 |
| ▸ | NPY4R | P50391 | 4/20 | 0.35 |
| ▸ | NPY1R | P25929 | 3/20 | 0.35 |
| ▸ | NPY2R | P49146 | 2/20 | 0.35 |
| ▸ | NPY5R | Q15761 | 2/20 | 0.35 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.33 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.33 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.33 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.33 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25303340 | 0.92 | OTC (0.38) | OTCDDAH1DPP7ALOX15CYP1A2 | |
| SCHEMBL30597599 | 0.92 | OTC (0.38) | OTCDDAH1DPP7ALOX15CYP1A2 | |
| SCHEMBL5872308 | 0.88 | DPP7 (0.39) | OTCDDAH1DPP7ALOX15CYP1A2 | |
| SCHEMBL25302510 | 0.87 | OTC (0.39) | OTCDDAH1DPP7ALOX15CYP1A2 | |
| Arginine SCHEMBL27680533 | 0.86 | OTC (0.51) | OTCDDAH1ALOX15CYP1A2MEN1 | |
| SCHEMBL2186462 | 0.84 | DPP7 (0.39) | OTCDDAH1DPP7ALOX15CYP1A2 | |
| SCHEMBL19465128 | 0.84 | DPP7 (0.39) | OTCDDAH1DPP7ALOX15CYP1A2 | |
| SCHEMBL2186467 | 0.84 | DPP7 (0.39) | OTCDDAH1DPP7ALOX15CYP1A2 | |
| SCHEMBL1690339 | 0.84 | CHRM2 (0.45) | OTCDPP7NPY4RNPY1RNPY2R | |
| Arginine SCHEMBL7928810 | 0.84 | OTC (0.56) | OTCDDAH1ALOX15CYP1A2MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12622967-B2 | Molecules, formulations, and methods for nutritional support of athletes, patients, and others | TODAY, INC. (US) | 2026-05-12 | — | — | US | disclosed |
| US-20240299548-A1 | MOLECULES, FORMULATIONS, AND METHODS FOR NUTRITIONAL SUPPORT OF ATHLETES, PATIENTS, AND OTHERS | TODAY, INC. (US) | 2024-09-12 | — | — | US | disclosed |
| US-12023382-B2 | Molecules, formulations, and methods for nutritional support of athletes, patients, and others | Today Inc. (US) | 2024-07-02 | — | — | US | disclosed |
| WO-2023139357-A1 | MOLECULES, NUTRITIONAL FORMULATIONS, AND METHODS OF PROVIDING NUTRITIONAL SUPPORT | Today Inc. (US) | 2023-07-27 | — | — | WO | disclosed |
| US-20230226187-A1 | MOLECULES, FORMULATIONS, AND METHODS FOR NUTRITIONAL SUPPORT OF ATHLETES, PATIENTS, AND OTHERS | Today Inc. (US) | 2023-07-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12622967-B2 | Molecules, formulations, and methods for nutritional support of athletes, patients, and others | SLC2A9, GYS1, SLC2A8 | OTC 354/4885DDAH1 4612/4885DPP7 3324/4885 |
| US-20240299548-A1 | MOLECULES, FORMULATIONS, AND METHODS FOR NUTRITIONAL SUPPORT OF ATHLETES, PATIENTS, AND OTHERS | CPT1B, GK, CPT1A | OTC 2007/4885DDAH1 1958/4885DPP7 4197/4885 |
| US-20230226187-A1 | MOLECULES, FORMULATIONS, AND METHODS FOR NUTRITIONAL SUPPORT OF ATHLETES, PATIENTS, AND OTHERS | CPT1B, GK, CPT1A | OTC 2007/4885DDAH1 1958/4885DPP7 4197/4885 |
| US-12023382-B2 | Molecules, formulations, and methods for nutritional support of athletes, patients, and others | CPT1B, GK, CPT1A | OTC 2007/4885DDAH1 1958/4885DPP7 4197/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.